DaVita Inc. (LON:0I7E)

London flag London · Delayed Price · Currency is GBP · Price in USD
142.83
-2.64 (-1.81%)
At close: Feb 21, 2025
16.15%
Market Cap 9.01B
Revenue (ttm) 10.24B
Net Income (ttm) 747.92M
Shares Out n/a
EPS (ttm) 8.57
PE Ratio 12.05
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 243
Average Volume 453
Open 144.12
Previous Close 145.47
Day's Range 141.44 - 144.82
52-Week Range 71.57 - 154.45
Beta 0.93
RSI 25.51
Earnings Date Feb 10, 2025

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1994
Employees 76,000
Stock Exchange London Stock Exchange
Ticker Symbol 0I7E
Full Company Profile

Financial Performance

In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.

Financial numbers in USD Financial Statements

News

Berkshire Hathaway further trims DaVita stake

DaVita (NYSE:DVA) stock in focus as Berkshire Hathaway (BRK.A.) (BRK.A) further reduces its stake with insider sales worth $116.1M of share. Read more here.

3 days ago - Seeking Alpha

Berkshire Hathaway sells another 750,000 DaVita shares

Warren Buffett's Berkshire Hathaway said it has sold an additional 750,000 shares of DaVita , reducing its stake in the kidney dialysis services provider by about 2% to 35.14 million shares worth $5.4...

3 days ago - Reuters

DaVita Inc (DVA) Celebrates Record Participation in Annual Fundraising Event

DaVita Inc (DVA) Celebrates Record Participation in Annual Fundraising Event

5 days ago - GuruFocus

Here’s why this Warren Buffett stock plunged 11% in a day

Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings … Continue reading The post Here’s why this Warren Buffett stock plun...

6 days ago - Finbold

DaVita (DVA) Stock Drops Following Earnings Report and Stake Reduction

DaVita (DVA) Stock Drops Following Earnings Report and Stake Reduction

8 days ago - GuruFocus

Why DaVita Inc Stock Is Plummeting Today

8 days ago - The Motley Fool

DaVita (DVA) Stock Declines Amid Weak Q4 Results

DaVita (DVA) Stock Declines Amid Weak Q4 Results

8 days ago - GuruFocus

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.

8 days ago - Market Watch

DaVita (DVA) Shares Decline as Berkshire Hathaway Reduces Stake

DaVita (DVA) Shares Decline as Berkshire Hathaway Reduces Stake

8 days ago - GuruFocus

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

9 days ago - CNBC

DaVita Plunges Over 10% In Friday Pre-Market After Warren Buffett Cuts Stake In One Of Berkshire Hathaway's Longest-Held Investments

The shares of DaVita Inc .(NYSE: DVA) plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook f...

9 days ago - Benzinga

DaVita Inc (DVA) Q4 2024 Earnings Call Highlights: Strong EPS Growth Amid Supply Chain Challenges

DaVita Inc (DVA) Q4 2024 Earnings Call Highlights: Strong EPS Growth Amid Supply Chain Challenges

9 days ago - GuruFocus

Warren Buffett's Berkshire Hathaway Sells Nearly $36 Million Worth Of Dialysis Giant DaVita's Shares Amid Q4 Earnings Beat

Warren Buffett 's Berkshire Hathaway Inc. (NYSE: BRK) (NYSE: BRK) has cut its stake in the dialysis provide DaVita Inc. (NYSE: DVA) according to a U.S. Securities Exchange Commission filing. What H...

9 days ago - Benzinga

Warren Buffett's Recent Transaction with DaVita Inc: A Strategic Portfolio Adjustment

Warren Buffett's Recent Transaction with DaVita Inc: A Strategic Portfolio Adjustment

9 days ago - GuruFocus

DaVita (DVA) Q4 2024 Earnings Call Transcript

DVA earnings call for the period ending December 31, 2024.

9 days ago - The Motley Fool

Berkshire sells some DaVita shares, cuts stake to 45%

Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 bi...

9 days ago - Reuters

DaVita forecasts 2025 profit below estimates, shares plummet

Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.

9 days ago - Reuters

DaVita Inc (DVA) Q4 2024 Earnings: EPS of $3.09 Beats Estimate, Revenue Hits $3. ...

DaVita Inc (DVA) Q4 2024 Earnings: EPS of $3.09 Beats Estimate, Revenue Hits $3.295 Billion Surpassing Expectations

9 days ago - GuruFocus

DaVita Inc. 4th Quarter 2024 Results

DENVER , Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished stron...

9 days ago - PRNewsWire

DaVita: Momentum Could Fade Given High Valuation

DaVita stock is currently trading at a premium compared to the historical average. Click here to see why DVA stock is a Hold.

18 days ago - Seeking Alpha

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

DENVER , Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:0...

23 days ago - PRNewsWire

Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.

25 days ago - CNBC Television

DaVita Inc Celebrates 25 Years of Transformative Kidney Care

DaVita Inc Celebrates 25 Years of Transformative Kidney Care

5 weeks ago - GuruFocus

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

DENVER , Jan. 15, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a pur...

5 weeks ago - PRNewsWire